key: cord-1016180-cezoqfen
authors: Suvvari, Tarun Kumar; Arigapudi, Nithya; Kandi, Venkata Ramana; Kutikuppala, LV Simhachalam
title: Mucormycosis: A Killer in the Shadow of COVID-19
date: 2021-05-31
journal: J Mycol Med
DOI: 10.1016/j.mycmed.2021.101161
sha: a42b2e422f97db4e07f5e73e2d29de533a000792
doc_id: 1016180
cord_uid: cezoqfen

nan

With the overwhelming of hospitals by COVID 19 patients, and the dilution of various physicians to cover the lack of manpower, the reliability of discovering a case through clinical diagnosis and diagnostics falls low, and perhaps this can be an explanation for the higher mortality rate seen now (~87%) as compared to non-covid times (~50%) [3, 4] . Any erroneous diagnosis, does more harm as the wrongly prescribed antibacterial or antifungal drugs may only aggravate and exacerbate the condition. Therefore, now more than ever, physicians must speculate a possible case of Mucormycosis when confronted with positive symptoms or signs.

One can rightly estimate that the refusal to pay heed to the rising numbers can be costly for the country, and in many places, we are already seeing these effects; as the availability of liposomal amphoterin B, the drug of choice in treating Mucormycosis, is falling short. With many physicians claiming to resort to a more toxic amphotericin b deoxycholate, and rising costs of available liposomal preparations, the country must get prepared in order to escape a future of panic and deaths. We are most definitely still in the early stages as many states have not yet reported cases, but the graph is expected to show only increasing numbers as indiscriminate use of steroids continues, with self-prescription not uncommon.

To fight a war is one thing, to fight two simultaneously is another, especially when one has already caused and is continuing to cause great destruction. Mucormycosis has been seen presenting itself in COVID 19 patients merely two to three days following their recovery, the repercussions of this cannot be measured only in terms of the mortality the disease causes; the financial burden, the mental strain, the future of the family, all should be considered. The only foreseeable way to overcome this added load on the already saddled back of India is to revaluate the usage of steroids in terms of dose and duration, alert the practicing physicians to prevent overlooking of the disease, all the while maintaining self-hygiene along with clean environment near your surroundings; after all, 'Prevention is better than cure'.

High mortality coinfections of COVID-19 patients: mucormycosis and other fungal infections

Post coronavirus disease mucormycosis: A deadly addition to the pandemic spectrum

Coronavirus Disease (Covid-19) Associated Mucormycosis (CAM): Case Report and Systematic Review of Literature

COVID-19 and Mucormycosis of the Craniofacial skeleton: Causal, Contributory or Coincidental